QCG
PFE icon

Quadrant Capital Group’s Pfizer PFE Stock Holding History

Quadrant Capital Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.87M Buy
173,339
+3,126
+2% +$83.2K 0.15% 102
2025
Q4 		$4.24M Sell
170,213
-1,971
-1% -$49.7K 0.13% 109
2025
Q3 		$4.39M Buy
172,184
+3,055
+2% +$75.4K 0.14% 101
2025
Q2 		$4.1M Buy
169,129
+122,772
+265% +$2.86M 0.15% 104
2025
Q1 		$1.17M Buy
46,357
+3,383
+8% +$88.5K 0.04% 332
2024
Q4 		$1.14M Sell
42,974
-15,329
-26% -$416K 0.08% 170
2024
Q3 		$1.69M Sell
58,303
-1,224
-2% -$35.7K 0.12% 125
2024
Q2 		$1.67M Buy
59,527
+10,611
+22% +$292K 0.12% 113
2024
Q1 		$1.36M Sell
48,916
-11,700
-19% -$325K 0.11% 139
2023
Q4 		$1.75M Sell
60,616
-6,481
-10% -$196K 0.15% 94
2023
Q3 		$2.23M Sell
67,097
-2,395
-3% -$84.7K 0.22% 62
2023
Q2 		$2.55M Sell
69,492
-92
-0.1% -$3.58K 0.25% 55
2023
Q1 		$2.84M Sell
69,584
-4,308
-6% -$186K 0.3% 49
2022
Q4 		$3.79M Buy
73,892
+9,786
+15% +$469K 0.43% 32
2022
Q3 		$2.81M Sell
64,106
-589
-0.9% -$28.6K 0.37% 36
2022
Q2 		$3.39M Sell
64,695
-2,298
-3% -$117K 0.46% 36
2022
Q1 		$3.47M Buy
66,993
+1,884
+3% +$97.8K 0.42% 40
2021
Q4 		$3.85M Buy
65,109
+17,066
+36% +$846K 0.46% 40
2021
Q3 		$2.07M Buy
48,043
+5,534
+13% +$245K 0.29% 52
2021
Q2 		$1.67M Sell
42,509
-424
-1% -$16.5K 0.24% 68
2021
Q1 		$1.55M Buy
42,933
+3,449
+9% +$122K 0.25% 63
2020
Q4 		$1.45M Buy
39,484
+1,846
+5% +$67.7K 0.27% 60
2020
Q3 		$1.31M Sell
37,638
-13,850
-27% -$486K 0.29% 60
2020
Q2 		$1.6M Buy
51,488
+3,522
+7% +$120K 0.35% 51
2020
Q1 		$1.49M Sell
47,966
-19,321
-29% -$658K 0.25% 75
2019
Q4 		$2.47M Buy
67,287
+7,321
+12% +$261K 0.3% 49
2019
Q3 		$2.03M Sell
59,966
-7,887
-12% -$287K 0.31% 54
2019
Q2 		$2.77M Buy
67,853
+1,650
+2% +$65.5K 0.44% 37
2019
Q1 		$2.65M Buy
66,203
+11,178
+20% +$448K 0.46% 35
2018
Q4 		$2.26M Sell
55,025
-2,165
-4% -$89.9K 0.6% 25
2018
Q3 		$2.37M Buy
57,190
+43
+0.1% +$1.66K 0.68% 25
2018
Q2 		$1.94M Buy
57,147
+379
+0.7% +$13K 0.68% 26
2018
Q1 		$1.89M Buy
56,768
+5,753
+11% +$198K 0.69% 26
2017
Q4 		$1.74M Buy
51,015
+1,301
+3% +$44.4K 0.69% 27
2017
Q3 		$1.66M Buy
49,714
+618
+1% +$19.9K 0.69% 24
2017
Q2 		$1.5M Buy
49,096
+1,011
+2% +$31.9K 0.66% 26
2017
Q1 		$1.55M Buy
48,085
+1,083
+2% +$34.1K 0.68% 27
2016
Q4 		$1.44M Buy
47,002
+14,984
+47% +$457K 0.72% 26
2016
Q3 		$1.02M Buy
32,018
+221
+0.7% +$7.39K 0.66% 26
2016
Q2 		$1.05M Buy
31,797
+813
+3% +$25.9K 0.72% 23
2016
Q1 		$860K Buy
30,984
+661
+2% +$18.9K 0.56% 29
2015
Q4 		$921K Sell
30,323
-356
-1% -$11.2K 0.64% 27
2015
Q3 		$909K Sell
30,679
-1,748
-5% -$56K 0.63% 29
2015
Q2 		$1.02M Buy
+32,427
New +$1.06M 0.65% 29

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Quadrant Capital Group's PFE Position: Q1 2026 in Review

Quadrant Capital Group increased its Pfizer (PFE) stake by 1.8% in Q1 2026, buying an estimated $83.2K and bringing the position to 173,339 shares worth $4.87M. The position accounts for 0.15% of the portfolio, ranked #102.

Quadrant Capital Group first reported a position in PFE in Q2 2015 and has held it in 44 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Quadrant Capital Group held 173,339 shares of Pfizer worth $4.87M as of Q1 2026.
  • Quadrant Capital Group bought 3,126 Pfizer shares in Q1 2026, an estimated $83.2K.
  • Pfizer made up 0.15% of Quadrant Capital Group's portfolio in Q1 2026, its #102 holding.
  • Quadrant Capital Group first reported a position in Pfizer in Q2 2015 and has held it in 44 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.